|
Delayed
Sao Paulo
13:30:52 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 92.25 BRL | +2.52% |
|
0.00% | +10.93% |
| 08-24 | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
| 08-24 | Takeda's Orzeryful Approved in Japan as First Treatment Targeting Narcolepsy Type 1 | MT |
Chart: Technical Analysis
Stock exchange
Sao Paulo
TAKP34 92.25 R$
+2.52%
92.25
R$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Japan Exchange
| 4502 | 5,809.00JPY | -0.87% | 14.85B ¥ | |
Tradegate
| TKD | 31.39EUR | -0.38% | 10.39K € | |
|
OTC Markets
| TKPHF | 36.62USD | -3.33% | 6.34K $ | |
|
Boerse Muenchen
| TKD | 31.23EUR | -1.11% | 31.23 € | |
|
Deutsche Boerse AG
| TKD | 30.98EUR | -1.49% | 0 € | |
|
Börse Stuttgart
| TKD | 31.25EUR | -0.35% | 0 € | |
|
Wiener Boerse
| TKD | 31.18EUR | +0.97% | 0 € | |
NYSE
| TAK | 18.08USD | -0.85% | 15.9M $ | |
|
CBOE
| TAK | 18.08USD | -0.93% | 372K $ | |
|
London S.E.
| 0A87 | 15.80USD | +0.83% | 15.8K $ | |
|
Tradegate
| TKDA | 15.40EUR | -1.91% | 13.86K € | |
|
Deutsche Boerse AG
| TKDA | 15.50EUR | -0.64% | 0 € | |
|
Börse Stuttgart
| TKDA | 15.40EUR | -0.65% | 0 € | |
|
Boerse Muenchen
| TKDA | 15.50EUR | -3.12% | 0 € | |
Sao Paulo
| TAKP34 | 92.25BRL | +2.52% | 92.25 R$ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4502 Stock
- TAKP34 Stock
- Charts Takeda Pharmaceutical Company Limited
Select your edition
All financial news and data tailored to specific country editions
